ResMed, Inc. (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $188.63 +1.26%
EPS Growth %: +13.3%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold
- Goldman Sachs Starts Chagee Holdings (CHA) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
